Tribulus Terrestris (Gokhru): Separating Real Evidence from Supplement Marketing Hype

Tribulus Terrestris — known locally as Gokhru — is probably the most heavily marketed men's herb in the world, appearing on almost every "testosterone booster" label from Lahore to Los Angeles. That kind of hype usually means one of two things: the herb genuinely works, or the marketing has run far ahead of the science. The honest answer for Tribulus is: a bit of both. It's the second-highest-dosed ingredient in Afrovit-SR after Ashwagandha.

What Is Tribulus Terrestris?

Tribulus is a small, spiny-fruited plant that grows wild across Pakistan, India, and the Mediterranean. Traditionally, it's been used in Ayurvedic and Unani medicine as a diuretic, a tonic for the urinary system, and a libido enhancer. Its reputation as a "testosterone herb" is largely a modern gym-supplement invention — the traditional use case was broader.

What the Clinical Research Actually Shows

This is where it's worth being precise, because the evidence is genuinely mixed:

• A Phase IV randomized, double-blind, placebo-controlled trial of 180 men aged 18–65 with mild-to-moderate erectile dysfunction or low sexual desire found a significant improvement in overall sexual function after 12 weeks of Tribulus extract versus placebo, with no serious adverse events.
• However, a broader systematic review of clinical trials on Tribulus and erectile dysfunction concluded the evidence has low methodological quality in about half of available studies, and found no robust evidence that Tribulus meaningfully raises testosterone levels — 8 of 10 reviewed studies showed no significant hormonal change.
• That same review did find that Tribulus supplementation at 400–750mg/day for 1–3 months improved erectile function in 3 of 5 studies that measured it — a meaningful, separate finding from the testosterone question.

The honest summary: Tribulus is not a reliable testosterone booster on the current evidence, but it does have some real support for improving sexual function and desire, independent of hormone levels — likely through its saponin content (notably protodioscin) supporting blood flow.

Tribulus's Role in Afrovit-SR

Afrovit-SR contains 80mg of Tribulus Terrestris per caplet, positioned as a supporting ingredient alongside the higher-dosed Ashwagandha (180mg) rather than as a standalone testosterone driver. This reflects what the evidence actually supports — Tribulus contributing to libido and performance support within a broader formula, not carrying the formula on its own.

As with any supplement, individual results vary, and Afrovit-SR is intended to support general male wellness and stamina, not to diagnose or treat a specific medical condition.

Frequently Asked Questions

Does Tribulus Terrestris raise testosterone?
Most clinical evidence says no, or not meaningfully. If testosterone is your primary concern, Ashwagandha has considerably stronger supporting evidence.

So why is Tribulus still worth including?
Because several trials show real improvements in sexual function and desire independent of testosterone — a different but relevant benefit for stamina and confidence.

Is Tribulus safe?
Clinical trials have generally reported it as well-tolerated with no serious adverse events at studied doses (400–750mg/day of extract). Afrovit-SR's 80mg dose sits within a formula designed for daily, long-term use.

Afrovit-SR combines 80mg of Tribulus Terrestris with Ashwagandha, Akarkara, and 16 other traditional herbs in one slow-release caplet. Available with cash on delivery and free shipping across Pakistan at slanaturals.com, or order directly via WhatsApp.

References

1. Kamenov Z, et al. "Evaluation of the Efficacy and Safety of Tribulus Terrestris in Male Sexual Dysfunction — A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial." Maturitas, 2017. PubMed
2. "Effects of Tribulus (Tribulus terrestris L.) Supplementation on Erectile Dysfunction and Testosterone Levels in Men — A Systematic Review of Clinical Trials." PMC, 2025. PMC
3. "Tribulus terrestris for management of patients with erectile dysfunction: a systematic review and meta-analysis of randomized trials." International Journal of Impotence Research, 2025. Nature